Regulatory and Peri-registration Activities Featured Image

Regulatory and Peri-registration Activities

30 Mar 23


A biotech company sought to register an antibiotic for an indication that was not considered acceptable by EU regulatory guidance, using a single small clinical trial in a condition of high medical need.


tranScrip undertook the preparation of clinical sections of the MAA based on the reanalysis of the data package previously submitted to FDA, maintained a close dialogue with agency assessors and key opinion leaders to champion the need in this indication and followed the registration process throughout including support for oral hearing.


The desired label indication was achieved.

Contact our team of experts

Our physicians, scientists and service experts can help to maximise the value of your products. Whatever your project requires, we have the people to meet your needs.